Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Renal Cell Carcinoma, Italian RCC Research

Camillo Porta

MD

🏢University of Bari Aldo Moro🌐Italy

Professor of Medical Oncology

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Camillo Porta at the University of Bari is a leading Italian kidney cancer specialist who has contributed to clinical trial research in RCC for over two decades. His work on VEGFR inhibitors, cabozantinib and lenvatinib combinations, and patient-reported outcomes in RCC has contributed to Italian and European treatment guidelines. He has been involved in multiple pivotal RCC trials.

Share:

🧪Research Fields 研究领域

renal cell carcinoma
VEGFR inhibitors
cabozantinib
lenvatinib combinations
Italian RCC trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Camillo Porta 的研究动态

Follow Camillo Porta's research updates

留下邮箱,当我们发布与 Camillo Porta(University of Bari Aldo Moro)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment